STOCK TITAN

Myomo (MYO) Financials

MYO NYSE
FY2025 annual
Revenue $40.9M +25.7% YoY
Net Income -$15.6M n/m YoY
EPS (Diluted) -$0.37 n/m YoY
Free Cash Flow -$16.3M n/m YoY
Market Cap $36.8M as of Nov 17, 2026
Price / Sales 0.8x on $45.5M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 13.4x on $2.8M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MYO SEC filings page.

Myomo Inc. (MYO) reported $40.9M in revenue for fiscal year 2025, up 25.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MYO FY2025

FY2025 growth exposed a cost-heavy model: revenue expanded, but margins, cash generation, and equity all deteriorated.

Cash conversion deteriorated alongside earnings in FY2025: a net loss of $15.6M came with operating cash flow of -$14.5M, so the reported loss was not mainly a non-cash accounting effect. Reinvestment intensified the shortfall: free cash flow reached -$16.3M against capital expenditures of $1.7M, making cash consumption worse than operating losses alone.

Revenue grew 25.7% in FY2025, while gross margin fell 5.5 percentage points, indicating that expansion came with weaker unit economics. SG&A increased 39.5%, so the larger sales base was absorbed by a heavier operating cost structure rather than converted efficiently into profit.

Liabilities reached 70.5% of assets in FY2025, up from 41.5% in FY2024; the balance sheet therefore carried a much larger liability share. Total equity fell 53.9%, while the current ratio was 3.3x, separating short-term coverage from the deeper shift in financing structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 46 / 100
Financial Health Score 46/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Myomo Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
41

Myomo Inc. held $18.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $14.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Myomo Inc. scores 41/100 among other emerging companies.

Dilution
47

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Myomo Inc. scores 47/100 on it among other emerging companies.

R&D Intensity
42

Myomo Inc. spent $6.9M on research and development in fiscal year 2025, which was 12.5% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Myomo Inc. scores 42/100 among other emerging companies.

Revenue Progress
77

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Myomo Inc. scores 77/100 on it among other emerging companies.

Burn Trend
18

Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Myomo Inc. scores 18/100 on it among other emerging companies.

Balance Sheet
51

Myomo Inc.'s cash, cash equivalents and investments came to $18.4M at the end of fiscal year 2025, against $27.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Myomo Inc. scores 51/100 among other emerging companies.

Altman Z-Score Distress
-3.06

Myomo Inc. scores -3.06, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $118.7M against total assets of $38.6M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

Myomo Inc. passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing
N/A

Myomo Inc. reported a net loss of $15.6M while operations used $14.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Myomo Inc. reported an operating loss of $14.4M against $451K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$12.3M
YoY+22.2%
QoQ+5.3%
5Y CAGR+23.0%

Myomo Inc. generated $12.3M in revenue in Q3 2026. This represents an increase of 22.2% from the same quarter a year earlier. Against the prior quarter it is up 5.3%.

EBITDA
-$1.3M
YoYn/m
QoQn/m
5Y CAGRn/m

Myomo Inc.'s EBITDA was -$1.3M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$4.2M
YoYn/m
QoQn/m
5Y CAGRn/m

Myomo Inc. reported a net loss of $4.2M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.10
YoYn/m
QoQn/m

Myomo Inc. earned -$0.10 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
-$1.4M
YoYn/m
QoQn/m

Myomo Inc. recorded an outflow of $1.4M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$11.1M
YoY-11.6%
QoQ-1.1%
5Y CAGR-2.5%
10Y CAGR+36.5%

Myomo Inc. held $11.1M in cash against $11.7M in long-term debt as of Q3 2026.

Shares Outstanding
40M
YoY+4.3%
QoQ+1.2%

Myomo Inc. had 40M shares outstanding in Q3 2026. This represents an increase of 4.3% from the same quarter a year earlier. Against the prior quarter it is up 1.2%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
71.3%
YoY+7.5pp
QoQ-0.8pp
5Y change-3.4pp

Myomo Inc.'s gross margin was 71.3% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 7.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Operating Margin
-14.0%
YoY+20.9pp
QoQ+5.3pp
5Y change+32.3pp

Myomo Inc.'s operating margin was -14.0% in Q3 2026, reflecting core business profitability. This is up 20.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.3 percentage points.

Net Margin
-34.3%
YoY+2.0pp
QoQ0.0pp
5Y change+12.6pp

Myomo Inc.'s net profit margin was -34.3% in Q3 2026, showing the share of revenue converted to profit. This is up 2.0 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Return on Equity
-153.9%
YoY-128.8pp
QoQ-84.9pp
5Y change-138.2pp

Myomo Inc.'s quarterly ROE was -153.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 128.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 84.9 percentage points.

Capital Allocation

R&D Spending
$1.8M
YoY+18.5%
QoQ+5.2%
5Y CAGR+23.1%

Myomo Inc. invested $1.8M in research and development in Q3 2026. This represents an increase of 18.5% from the same quarter a year earlier. Against the prior quarter it is up 5.2%.

Capital Expenditures
$51K
YoY-95.2%
QoQ+56.5%

Myomo Inc. invested $51K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 95.2% from the same quarter a year earlier. Against the prior quarter it is up 56.5%.

Share Buybacks

Not reported for Q3 2026.

MYO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MYO quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$12.3M+22.2%$11.7M+21.3%$10.1M+2.9%$11.4M-5.9%$10.1M+9.6%$9.7M+28.3%$9.8M+161.9%$12.1M+153.7%
Cost of Revenue$3.5M-3.0%$3.3M-9.4%$3.2M-0.3%$3.6M+3.4%$3.6M+61.3%$3.6M+64.0%$3.2M+121.4%$3.5M+109.1%
Gross Profit$8.8M+36.4%$8.4M+39.5%$6.9M+4.4%$7.8M-9.6%$6.4M-7.2%$6.1M+13.6%$6.6M+187.5%$8.6M+177.5%
R&D Expenses$1.8M+18.5%$1.7M-14.0%$1.6M-9.3%$1.6M+4.2%$1.5M+22.3%$2.0M+98.7%$1.8M+87.2%$1.6M+77.6%
SG&A Expenses$8.7M+3.2%$9.0M+3.9%$8.4M+1.1%$8.9M+22.4%$8.4M+26.7%$8.6M+59.0%$8.3M+59.4%$7.3M+56.7%
Operating Income-$1.7Mn/m-$2.3Mn/m-$3.2Mn/m-$2.8Mn/m-$3.5Mn/m-$4.6Mn/m-$3.5Mn/m-$245Kn/m
EBITDA-$1.3Mn/m-$1.9Mn/m-$2.9Mn/m-$2.3M-1150.9%-$3.3Mn/m-$4.4Mn/m-$3.4Mn/m$221Kn/m
Interest Expense$560K+5645.4%$536K$505KN/A$10KN/AN/AN/A
Income Tax$104K-23.4%$31K-78.8%$187K+36.5%$84K-1.1%$136K+59.8%$148K+30.2%$137K+66.5%$85K+19.8%
Net Income-$4.2Mn/m-$4.0Mn/m-$3.0Mn/m-$3.8Mn/m-$3.7Mn/m-$4.6Mn/m-$3.5Mn/m-$260Kn/m
EPS (Basic)-$0.10n/m-$0.09n/m-$0.07n/m-$0.09n/m-$0.09n/m-$0.11n/m-$0.08n/m$0.00n/m
EPS (Diluted)-$0.10n/m-$0.09n/m-$0.07n/m-$0.09n/m-$0.09n/m-$0.11n/m-$0.08n/m$0.00n/m
Diluted Shares (Avg)44M+3.3%43M+2.7%42M+2.0%N/A42M+11.1%42M+11.3%41M+12.8%N/A

MYO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MYO quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$33.8M-0.8%$35.3M-8.6%$36.8M-10.1%$38.6M-8.5%$34.1M+108.9%$38.7M+138.9%$40.9M+147.4%$42.2M+189.7%
Current Assets$23.5M+2.4%$24.5M-12.5%$25.7M-17.5%$27.6M-16.0%$22.9M+56.1%$28.0M+85.2%$31.1M+98.0%$32.8M+140.2%
Cash & Equivalents$11.1M-11.6%$11.2M-21.2%$11.4M-42.4%$14.1M-42.0%$12.6M+89.6%$14.2M+143.6%$19.8M+264.2%$24.4M+254.7%
Short-Term Investments$847Kn/m$2.2M+79.9%$4.3M0.0%$4.3M+764.5%$0n/m$1.2M-60.4%$4.3M-22.2%$493K-75.3%
Inventory$3.1M-15.1%$3.2M-23.2%$3.5M+5.3%$3.1M-1.4%$3.6M+7.7%$4.1M+58.6%$3.4M+41.1%$3.2M+75.5%
Accounts Receivable$5.9M+11.9%$4.9M-29.9%$4.8M+3.5%$4.1M+7.1%$5.3M+41.9%$7.1M+179.2%$4.7M+177.0%$3.8M+60.5%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$31.1M+59.6%$29.5M+40.2%$27.8M+44.7%$27.2M+55.4%$19.5M+177.1%$21.1M+223.3%$19.2M+241.2%$17.5M+213.5%
Current Liabilities$12.3M+33.3%$10.6M-9.7%$9.4M-19.6%$8.3M-18.0%$9.2M+31.6%$11.8M+81.8%$11.7M+110.1%$10.2M+85.7%
Non-Current Liabilities$18.8M+83.3%$18.9M+103.2%$18.4M+144.7%$18.9M+156.7%$10.2M+35042.8%$9.3M+19553.2%$7.5M+11517.8%$7.4M+6289.5%
Long-Term Debt$11.7M+382.3%$11.5M+764.9%$10.9M$11.2M0.0%$2.4M$1.3MN/A$11.2M
Total Equity$2.8M-81.2%$5.8M-66.9%$9.0M-58.5%$11.4M-53.9%$14.6M+57.4%$17.6M+82.0%$21.7M+99.0%$24.7M+174.9%
Retained Earnings-$130.0Mn/m-$125.7Mn/m-$121.7Mn/m-$118.7Mn/m-$114.9Mn/m-$111.2Mn/m-$106.6Mn/m-$103.1Mn/m

Not reported in any period shown, so not listed: Goodwill.

MYO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MYO quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$1.3Mn/m-$1.9Mn/m-$2.2Mn/m-$1.1M-133.9%-$1.8Mn/m-$8.9Mn/m-$2.7Mn/m$3.4Mn/m
Depreciation & Amortization$406K+64.3%$385K+101.5%$292K+84.0%$454K-2.5%$247K+103.6%$191K+88.2%$158K+79.3%$466K+481.0%
Stock-Based Compensation$1.3M+125.4%$1.0M+164.0%$597K+10.6%N/A$584K+80.1%$395Kn/m$540K+68.7%N/A
Capital Expenditures$51K-95.2%$32K-85.4%$328K-51.1%N/A$1.1M+228.3%$221K+85.6%$671K+1021.4%$860K+2616.7%
Free Cash Flow-$1.4Mn/m-$2.0Mn/m-$2.5Mn/mN/A-$2.9Mn/m-$9.1Mn/m-$3.3Mn/m$2.5Mn/m
Investing Cash Flow$1.3M+595.7%$2.0Mn/m-$494Kn/m-$4.6Mn/m$190K-93.3%-$757K-132.5%-$1.9Mn/m-$1.4M-159.0%
Financing Cash Flow-$127Kn/m-$244K-106.1%$0n/m$7.5M-52.4%-$50Kn/m$4.0Mn/m-$37K-100.7%$15.8M+50870932.3%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MYO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MYO quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin71.3%+7.5pp72.1%+9.4pp68.2%+1.0pp68.6%-2.8pp63.8%-11.6pp62.7%-8.1pp67.2%+6.0pp71.4%+6.1pp
Operating Margin-14.0%+20.9pp-19.3%+28.3pp-31.2%+4.6pp-24.4%-22.4pp-34.9%-24.5pp-47.6%-32.7pp-35.8%-2.0%+49.1pp
Net Margin-34.3%+2.0pp-34.4%+13.6pp-29.8%+5.5pp-33.6%-31.4pp-36.3%-25.8pp-48.0%-33.1pp-35.2%-2.2%+49.6pp
Return on Equity-153.9%-128.8pp-69.0%-42.7pp-33.4%-17.4pp-33.4%-32.4pp-25.0%-14.6pp-26.3%-14.7pp-16.0%+19.2pp-1.1%+26.3pp
Return on Assets-12.5%-1.8pp-11.4%+0.6pp-8.2%+0.3pp-9.9%-9.3pp-10.8%-4.8pp-12.0%-5.1pp-8.5%+14.7pp-0.6%+16.2pp
Current Ratio1.92-0.6x2.31-0.1x2.73+0.1x3.30+0.1x2.49+0.4x2.390.0x2.66-0.2x3.22+0.7x
Debt-to-Equity4.24+4.1x1.98+1.9x1.210.98+0.5x0.170.08N/A0.45
Liabilities-to-Equity11.29+10.0x5.06+3.9x3.08+2.2x2.39+1.7x1.33+0.6x1.20+0.5x0.88+0.4x0.71+0.1x
Asset Turnover0.36+0.1x0.33+0.1x0.280.0x0.290.0x0.30-0.3x0.25-0.2x0.240.0x0.290.0x
FCF Margin-11.0%+17.6pp-16.9%+77.3pp-25.0%+9.1ppN/A-28.6%-8.9pp-94.1%-67.1pp-34.1%+54.0pp20.8%+71.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Myomo Inc. MYO FY2025 $40.9M -$15.6M -38.0% $36.8M 46/100
electroCore, Inc. ECOR FY2025 $32.0M -$14.0M -43.6% $44.2M 57/100
Spectral AI, Inc. MDAI FY2025 $19.6M -$7.6M -38.5% $43.3M 46/100
TELA Bio, Inc. TELA FY2025 $80.3M -$38.8M -48.4% $34.4M 48/100
Xtant Medical Holdings, Inc. XTNT FY2025 $133.9M $5.0M 3.7% $28.8M 53/100
Sensus Healthcare, Inc SRTS FY2025 $27.5M -$7.7M -28.1% $37.2M 50/100

Frequently Asked Questions

Myomo Inc. (MYO) reported $40.9M in total revenue for fiscal year 2025. This represents a 25.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Myomo Inc. (MYO) revenue grew by 25.7% year-over-year, from $32.6M to $40.9M in fiscal year 2025.

No, Myomo Inc. (MYO) reported a net loss of $15.6M in fiscal year 2025, with a net profit margin of -38.0%.

Myomo Inc. (MYO) reported diluted earnings per share of -$0.37 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Myomo Inc. (MYO) had EBITDA of -$12.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Myomo Inc. (MYO) had $14.1M in cash and equivalents against $11.2M in long-term debt.

Myomo Inc. (MYO) had a gross margin of 65.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Myomo Inc. (MYO) had an operating margin of -35.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Myomo Inc. (MYO) had a net profit margin of -38.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Myomo Inc. (MYO) has a return on equity of -136.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Myomo Inc. (MYO) recorded an outflow of $16.3M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Myomo Inc. (MYO) recorded an outflow of $14.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Myomo Inc. (MYO) had $38.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Myomo Inc. (MYO) invested $1.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Myomo Inc. (MYO) invested $6.9M in research and development during fiscal year 2025.

Myomo Inc. (MYO) had 39M shares outstanding as of fiscal year 2025.

Myomo Inc. (MYO) had a current ratio of 3.30 as of fiscal year 2025, which is generally considered healthy.

Myomo Inc. (MYO) had a debt-to-equity ratio of 0.98 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Myomo Inc. (MYO) had a liabilities-to-equity ratio of 2.39 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Myomo Inc. (MYO) had a return on assets of -40.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Myomo Inc. (MYO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $36.8M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Myomo Inc. (MYO) trades at 0.8x sales, its market capitalization divided by $45.5M revenue, trailing 12 months to September 30, 2026. The market capitalization is $36.8M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Myomo Inc. (MYO) held $18.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $14.5M over that year. Dividing the one by the other, the reported balance equals about 15 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Myomo Inc. (MYO) has an Altman Z-Score of -3.06, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Myomo Inc. (MYO) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Myomo Inc. (MYO) reported a net loss of $15.6M while operations used $14.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Myomo Inc. (MYO) reported an operating loss of $14.4M against $451K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Myomo Inc. (MYO) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top